BRCA1 and breast carcinoma: The effect of C/EBPβ on PARPi responsiveness was also observed in the HR-proficient breast cancer cell line MDA-MB-231, but not in the BRCA1-mutant MDA-MB-436 (Supplementary Figs. S10, S11).